HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cross-Sectional Associations between HDL Structure or Function, Cell Membrane Fatty Acid Composition, and Inflammation in Elderly Adults.

AbstractBACKGROUND:
Cell membrane fatty acid composition has been related to inflammation and cardiovascular disease (CVD) risk. Dysregulation of HDL function is also considered a CVD risk factor.
OBJECTIVES:
We aimed to investigate whether the content of cell membrane fatty acids and HDL functionality are linked to each other as well as to inflammation.
METHODS:
This cross-sectional analysis involved 259 participants (mean age: 67.9 y) with overweight/obesity (mean BMI: 29.5 kg/m2) from a coronary artery disease case-control study nested within the PREDIMED (PREvención con DIeta MEDiterránea) trial for which HDL functional parameters [apoA-I, apoA-IV, and apoC-III; cholesterol efflux capacity (CEC); HDL oxidative inflammatory index (HOII); sphingosine-1-phosphate (S1P); serum amyloid A (SAA); and complement-3 (C3) protein] were quantified. We also assessed 22 fatty acids in blood cell membranes using GC and inflammatory markers (IFN-γ and IL-1b, IL-6, IL-8, and IL-10) in serum. Associations of HDL-related variables with cell membrane fatty acids and with inflammatory markers were assessed using multivariable linear regression analyses with elastic net penalty.
RESULTS:
ApoA-I, apoC-III, CEC, HOII, S1P, and SAA, but not apoA-IV and C3 protein, were associated with membrane fatty acids. S1P and SAA were directly associated with IL-6, whereas apoA-I and C3 protein showed inverse associations with IL-6. Specific fatty acids including myristic acid (14:0) and long-chain n-6 fatty acids being negatively and positively associated with IL-8, respectively, were also found to be positively associated with SAA.
CONCLUSIONS:
This study suggests interrelations between indicators of inflammation and both blood cell membrane fatty acid composition and HDL structure/functional parameters in a Mediterranean population at high CVD risk.This trial was registered at www.isrctn.com as ISRCTN35739639.
AuthorsJananee Muralidharan, Christopher Papandreou, Maria T Soria-Florido, Aleix Sala-Vila, Gemma Blanchart, Ramon Estruch, Miguel A Martínez-González, Dolores Corella, Emilio Ros, Miguel Ruiz-Canela, Montse Fito, Jordi Salas-Salvadó, Mònica Bulló
JournalThe Journal of nutrition (J Nutr) Vol. 152 Issue 3 Pg. 789-795 (03 03 2022) ISSN: 1541-6100 [Electronic] United States
PMID34637509 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
Chemical References
  • Apolipoprotein A-I
  • Apolipoprotein C-III
  • Biomarkers
  • Cholesterol, HDL
  • Fatty Acids
  • Interleukin-6
  • Interleukin-8
Topics
  • Aged
  • Apolipoprotein A-I
  • Apolipoprotein C-III
  • Biomarkers
  • Cardiovascular Diseases (epidemiology)
  • Case-Control Studies
  • Cell Membrane
  • Cholesterol, HDL
  • Cross-Sectional Studies
  • Fatty Acids
  • Humans
  • Inflammation
  • Interleukin-6
  • Interleukin-8

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: